ABC | Volume 114, Nº2, Fevereiro 2020

Atualização Atualização da Diretriz Brasileira de Cardiologia Nuclear – 2020 Arq Bras Cardiol. 2020; 114(2):325-429 cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart. 1999;81(3):262-70. 210. Mc Ardle BA, Leung E, Ohira H, Cocker MS, deKemp RA, DaSilva J, et al. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20(2):297-306. 211. Tahara N, Imaizumi T, Virmani R, Narula J. Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med. 2009;50(3):331-4. 212. Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med. 2003;44(7):1030-6. 213. Padilha BG, Sabino D, Giorgi MC, Soares J Jr, Izaki M, Meneghetti JC. Case Report: Multivessel Coronary Disease Assessment with SPECT 99mTc-Sestamibi and Rubidium-82 PET/CT. Arq Bras Cardiol. 2017;108(1):87-90. 214. Senthamizhchelvan S, Bravo PE, LodgeMA, Merrill J, Bengel FM, Sgouros G. Radiation dosimetry of 82Rb in humans under pharmacologic stress. J Nucl Med. 2011;52(3):485-91. 215. ChowBJ, Beanlands RS, Lee A, DaSilva JN, deKemp RA, Alkahtani A, et al. Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. J Am Coll Cardiol. 2006;47(2):411-6. 216. Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester HJ, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med. 2008;49(4):630-6. 217. Maddahi J. Properties of an ideal PET perfusion tracer: new PET tracer cases and data. J Nucl Cardiol. 2012;19(Suppl 1):S30-7 218. Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009;119(17):2333-42. 219. Yu M, Guaraldi MT, Mistry M, Kagan M, McDonald JL, Drew K, et al. BMS-747158-02: a novel PETmyocardial perfusion imaging agent. J Nucl Cardiol. 2007;14(6):789-98. 220. Ziadi MC, Beanlands RS. The clinical utility of assessing myocardial blood flow using positron emission tomography. J Nucl Cardiol. 2010;17(4):571-81. 221. Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60(18):1828-37. 222. Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging. 2012;5(6):700-7. 223. Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol. 1991;67(16):1303-10. 224. Parkash R, de Kemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, et al. Potential utility of rubidium82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol. 2004;11(4):440-9. 225. Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJ, et al. Doesquantificationofmyocardial flowreserveusingrubidium-82positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol. 2012;19(4):670-80. 226. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213-24. 227. Johnson NP, Gould KL. Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging. 2012;5(4):430-40. 228. Johnson NP, Kirkeeide RL, Gould KL. Is discordance of coronary flow reserveandfractionalflowreserveduetomethodologyorclinicallyrelevant coronarypathophysiology?JACCCardiovascImaging.2012;5(2):193-202. 229. Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2013;61(2):176-84. 230. AdenawN,SalernoM.PET/MRI:currentstateoftheartandfuturepotential for cardiovascular applications. J Nucl Cardiol. 2013;20(6):976-89. 231. Heller GV, CalnonD, Dorbala S. Recent advances in cardiac PET and PET/ CT myocardial perfusion imaging. J Nucl Cardiol. 2009;16(6):962-9. 232. Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131(1):19-27. 233. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003. 234. Vítola JV. A need to reduce premature CV mortality in the developing world: How could appropriate use of non-invasive imaging help? J Nucl Cardiol. 2019;26(3):975-985. 235. Vítola JV, Wanderley MR Jr, Cerci RJ, Pereira Neto CC, Kormann O, Neto OF, et al. Outcome of patients with high-risk Duke treadmill score and normal myocardial perfusion imaging on spect. J Nucl Cardiol. 2016;23(6):1291-300. 236. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi- Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113(1):30-7. 237. Shaw LJ, Giambrone AE, Blaha MJ, Knapper JT, Berman DS, Bellam N, et al. Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients: A Cohort Study. Ann Intern Med. 2015;163(1):14-21. 238. Kelkar AA, Schultz WM, Khosa F, Schulman-Marcus J, O'Hartaigh BW, Gransar H, et al. Long-Termprognosis after coronary artery calciumscoring among low-intermediate risk women andmen. Circ Cardiovasc Imaging. 2016;9(4): e003742. 239. Chang SM, Nabi F, Xu J, Pratt CM, Mahmarian AC, Frias ME, et al. Value of CACScomparedwithETTandmyocardialperfusion imaging forpredicting long-term cardiac outcome in asymptomatic and symptomatic patients at low risk for coronary disease: clinical implications in a multimodality imaging world. JACC Cardiovasc Imaging. 2015;8(2):134-44. 240. Cho I, Chang HJ, ÓHartaigh B, Shin S, Sung JM, Lin FY, et al. Incremental prognostic utility of coronary CT angiography for asymptomatic patients based upon extent and severity of coronary artery calcium: results from the CoronaryCTAngiographyEvaluatioNForClinicalOutcomes InteRnational Multicenter (CONFIRM) study. Eur Heart J. 2015;36(8):501-8. 241. Rana JS, Rozanski A, Berman DS. Combination of myocardial perfusion imaging and coronary artery calcium scanning: potential synergies for improving risk assessment in subjects with suspected coronary artery disease. Curr Atheroscler Rep. 2011;13(5):381-9. 242. Cerci RJ, Zapparoli M, Cunha C, Cerci JJ, Kormann OJ, Stier AL Jr, et al; P26 Coronary calcium score ability to predict ischemia in patients from a developing nation. Moderated Posters Session- Ischaemia Detection. Eur Heart J- Cardiovasc Imaging. 2017;18(1):i7–9. 243. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ; COURAGETrialResearchGroup.Optimalmedicaltherapywithorwithout PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-16. 422